| prov:value
| - The FDA also advises that these patients be observed for certain behaviors associated with these drugs, such as anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, severe restlessness, hypomania, and mania, and that physicians be particularly vigilant in patients who may have bipolar disorder.
|